Predictors for heparin resistance in patients undergoing coronary artery bypass grafting

Perfusion. 1999 Nov;14(6):437-42. doi: 10.1177/026765919901400606.

Abstract

Heparin resistance (HR) is a common event in cardiac operations. At present, no clear recognition of the risk factors for HR has been reached. The aim of this study was to determine a predictive model for HR, based on the preoperative patient's profile. Two hundred consecutive patients scheduled for elective coronary artery bypass operations were enrolled in a prospective trial. Demographics, type of preoperative anticoagulation therapy and preoperative coagulation profile were collected and statistically analysed with respect to the evidence of a HR. Heparin resistance was defined as at least one activated clotting time < 400 s after heparinization and/or the need for purified antithrombin III (AT-III) administration. With a multivariate analysis we could identify five predictors for HR: AT-III < or = 60%; preoperative subcutaneous heparin therapy; intravenous heparin therapy; platelet count > or = 300000 cells/mm3; age > or = 65 years. We conclude that HR is a predictable event. In the presence of all the risk factors, the likelihood of HR is 99%; in the absence of all of them, it is 10%. Predicting HR allows us to apply many possible therapeutic strategies.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antithrombin III / drug effects
  • Blood Coagulation / drug effects
  • Coronary Artery Bypass*
  • Drug Resistance
  • Female
  • Heparin / therapeutic use*
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Platelet Count / drug effects
  • Prospective Studies
  • Risk Factors
  • Whole Blood Coagulation Time

Substances

  • Antithrombin III
  • Heparin